3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
132
Myelodysplastic Syndromes
57
Leukemia
32
Leukemia, Myelomonocytic, Chronic
23
Recurrence
18
Lymphoma, Large B-Cell, Diffuse
10
Myeloproliferative Disorders
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Congenital Abnormalities
7
Primary Myelofibrosis
6
Melanoma
6
Hodgkin Disease
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Blast Crisis
5
Thrombocythemia, Essential
4
Polycythemia Vera
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma
4
Leukemia, Monocytic, Acute
4
Leukemia, Biphenotypic, Acute
4
Anemia, Refractory, with Excess of Blasts
4
Neoplasm Metastasis
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Interventions
Nivolumab
13
Ipilimumab
10
pembrolizumab
8
cemiplimab
6
Surveys and Questionnaires
6
Biopsy
6
aldesleukin
5
Radiotherapy
5
Interleukin-2
5
Blood Specimen Collection
5
Temozolomide
4
Sirolimus
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Fluorouracil
4
Educational Status
4
Cyclophosphamide
4
sonidegib
3
fludarabine phosphate
3
fludarabine
3
avelumab
3
Vemurafenib
3
Surgical Procedures, Operative
3
Radiation
3
Petrolatum
3
Cetuximab
3
Aminolevulinic Acid
3
trametinib
2
dabrafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Skin Neoplasms
×
Decitabine
×
Clear all
NCT00715793
2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2
Completed
39 enrolled
12 charts